Rare diseases
Investigational molecules
Locations
A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
AustriaA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
AustriaPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
AustriaA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
AustriaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
AustriaA study of navenibart for long-term safety in patients with hereditary angioedema
AustriaA study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors
AustriaA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
AustriaA study testing duvakitug for patients with moderately to severely active ulcerative colitis
AustriaA Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread
AustriaStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
AustriaStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
